Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:
Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)
Call for papers - Neurogenomics: from the bench to the clinic
Genome Medicine is calling for submissions to a new Collection on the interpretation and application of genetic and genomic variation in the prevention, diagnosis, and treatment of neurological disorders, guest edited by Daniel Geschwind and Jessica Rexach. Deadline 2 September 2025.
Call for papers - Respiratory viruses: surveillance, diagnostics, and emergence
Genome Medicine is calling for submissions to a new Collection on current research on the surveillance, diagnostics, and emergence of respiratory viruses, guest edited by Jasper Fuk-Woo Chan and Vivian Huiping Shuai. Deadline 4 July 2025.
Call for papers - AI applications in cancer discovery and care
Genome Medicine is calling for submissions to a new Collection on how artificial intelligence in oncology has increased dramatically in recent years, evolving from basic algorithm development research toward incorporation into clinical application, guest edited by Dr Jakob Nikolas Kather from Dresden University of Technology and Dr Mihaela Aldea from Gustave Roussy. Deadline 10 June 2025.
Call for papers - Clinical trials resource
Genome Medicine is pleased to announce a call for papers for our Clinical Trials Resource, guest edited by Christophe Le Tourneau from the Institut Curie. We encourage work from academic-industry partnerships as well as collaboration among scientists from multi-disciplinary fields. Deadline 6 June 2025.
Call for papers - Genomic research and clinical interventions for rare diseases
Genome Medicine is calling for submissions to a new Collection on genomic research and clinical advances in rare diseases, guest edited by Anna Lindstrand and Claudia Carvalho. Deadline 16 April 2025.
Call for papers - Advances in healthy aging and age-related diseases
Genome Medicine is calling for submissions to a new Collection on advances in healthy aging and
age-related diseases, guest edited by Joris Deelen and Henne Holstege. Deadline 1 April 2025.
Call for papers - Tumor immune contexture in cancer progression and treatment
Genome Medicine is calling for submissions to a new Collection on Tumor immune contexture in cancer progression and treatment guest edited by Noel De Miranda. Deadline 31 December 2024.
Call for papers - Translating the microbiome in health and disease
Genome Medicine is calling for submission to a new Collection on translating the microbiome in health and disease guest edited by Peggy Lai. Deadline 1 December 2024.
Reviews, Research Highlights and Commentaries
Articles
-
-
pVACview: an interactive visualization tool for efficient neoantigen prioritization and selection
-
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
-
KleTy: integrated typing scheme for core genome and plasmids reveals repeated emergence of multi-drug resistant epidemic lineages in Klebsiella worldwide
-
Identification of pathological pathways centered on circRNA dysregulation in association with irreversible progression of Alzheimer’s disease
-
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
-
Best practices for variant calling in clinical sequencing
-
The Human Genome Project: big science transforms biology and medicine
-
An introduction to spatial transcriptomics for biomedical research
-
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Focus: The human microbiome in health and disease
Read the latest Research and and Reviews on the human microbiome in health and disease:
Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides
Langdon, A., Schwartz, D.J., Bulow, C. et al. Genome Med 13, 28 (2021)
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Hayase, E., Jenq, R.R. Genome Med 13, 107 (2021)
Strain-level epidemiology of microbial communities and the human microbiome
Yan, Y., Nguyen, L.H., Franzosa, E.A. et al. Genome Med 12, 71 (2020).
Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma
Usyk, M., Pandey, A., Hayes, R.B. et al. Genome Med 13, 160 (2021).
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, cardiology, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Article collections
Special issue
Cardiovascular disease: omics approaches and clinical applications
Guest editors: James Ware and Connie Bezzina
Special issue
New technology applications in health and disease
Guest editors: Fei Chen and Francisco De La Vega
Special issue
Advancing human genetics in underrepresented populations
Guest editors: Segun Fatumo and Krishna Aragam
Special issue
Dissecting the role of immune responses in complex brain disorders: translational and clinical insights
Guest editors: Philip de Jager and Carlos Cruchaga
Resource
Coronavirus Resource - Submit your latest research and discoveries
Guest editor: Junhua Li
Special issue
Targeting cancer evolution in the clinic
Guest editors: Razelle Kurzrock and Alberto Bardelli
From the blog
Failed to load RSS feed.
- Editorial Board
- Call for EBMs
- Call for papers
- Sign up for article alerts and news from this journal
- Manuscript editing services
- Contact us
-
Announcements
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 10.4
5-year Journal Impact Factor: 12.6
Source Normalized Impact per Paper (SNIP): 2.375
SCImago Journal Rank (SJR): 4.975Speed 2023
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 185Usage 2023
Downloads: 2,331,772
Altmetric mentions: 4,916 -
Peer Review Taxonomy
This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here.
The following summary describes the peer review process for this journal:
- Identity transparency: Single anonymized
- Reviewer interacts with: Editor
- Review information published: None
We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.